DE2264903C3 - Piperidine derivatives and their preparation - Google Patents
Piperidine derivatives and their preparationInfo
- Publication number
- DE2264903C3 DE2264903C3 DE2264903A DE2264903A DE2264903C3 DE 2264903 C3 DE2264903 C3 DE 2264903C3 DE 2264903 A DE2264903 A DE 2264903A DE 2264903 A DE2264903 A DE 2264903A DE 2264903 C3 DE2264903 C3 DE 2264903C3
- Authority
- DE
- Germany
- Prior art keywords
- oxy
- formula
- ethanol
- benzyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title claims description 4
- 150000003053 piperidines Chemical class 0.000 title claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 22
- 239000003054 catalyst Substances 0.000 claims description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- MLEGMEBCXGDFQT-UHFFFAOYSA-N 1-benzylpiperidin-2-one Chemical class O=C1CCCCN1CC1=CC=CC=C1 MLEGMEBCXGDFQT-UHFFFAOYSA-N 0.000 claims description 5
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002841 Lewis acid Substances 0.000 claims description 3
- 238000005984 hydrogenation reaction Methods 0.000 claims description 3
- 150000007517 lewis acids Chemical class 0.000 claims description 3
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims description 2
- 150000004791 alkyl magnesium halides Chemical class 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 85
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 56
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 47
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 16
- 229910052739 hydrogen Inorganic materials 0.000 description 13
- 239000001257 hydrogen Substances 0.000 description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000012230 colorless oil Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 7
- -1 methyl mercapto Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- AOAMQMAEEUONRT-UHFFFAOYSA-N 8-benzyl-1,4-dioxa-8-azaspiro[4.5]decane Chemical compound C=1C=CC=CC=1CN(CC1)CCC21OCCO2 AOAMQMAEEUONRT-UHFFFAOYSA-N 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 4
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 4
- YYZUSRORWSJGET-UHFFFAOYSA-N ethyl octanoate Chemical compound CCCCCCCC(=O)OCC YYZUSRORWSJGET-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229940102396 methyl bromide Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- LSXKDWGTSHCFPP-UHFFFAOYSA-N 1-bromoheptane Chemical compound CCCCCCCBr LSXKDWGTSHCFPP-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- ZKGKJSFHHJHLTP-UHFFFAOYSA-N 9-benzyl-1,5-dioxa-9-azaspiro[5.5]undecane Chemical compound C=1C=CC=CC=1CN(CC1)CCC21OCCCO2 ZKGKJSFHHJHLTP-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- OYKIERKRPUDEIV-UHFFFAOYSA-N decane;hydrochloride Chemical compound Cl.CCCCCCCCCC OYKIERKRPUDEIV-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Die Erfindung betrifft Piperidinderivate der Formel Z'The invention relates to piperidine derivatives of the formula Z '
(D O-CHa-iCH^-CHj-O-A(D O-CHa-iCH ^ -CHj-O-A
in der bedeuten:
R H oder Benzyl,in which:
RH or benzyl,
X=Cl, Trifluormethyl, Methoxy oder Methylmercapto, X = Cl, trifluoromethyl, methoxy or methyl mercapto,
B = H oder Methyl,
Z' = H oder C,- bis Cio-Aikyi,
A = H oder eine Gruppe R,—CO mit R = Ci- bis da-AlkylB = H or methyl,
Z '= H or C, - to Cio-Aikyi,
A = H or a group R, —CO with R = Ci- to da-alkyl
und
n=0, 1 oder 2,and
n = 0, 1 or 2,
die in der DE-PS 22 22 931 beschrieben sind und ihrerseits aufgrund ihrer neuroleptischen, analgetischen, spasmolytischen und Antihistaminwirkung besonders in der Humanmedizin wertvollt Pharmaka darstellen.which are described in DE-PS 22 22 931 and for their part due to their neuroleptic, analgesic, spasmolytic and antihistamine effects, especially in represent valuable pharmaceuticals in human medicine.
Zur Herstellung dieser Verbindungen werden die erfindungsgemäßen Zwischenprodukte mit 10-(O)-HaIogenalkyl)-phenothiazinen der Formel XTo prepare these compounds, the intermediates according to the invention are made with 10- (O) -haloalkyl) -phenothiazines of formula X
Z' H oder eine Gruppe ZZ 'H or a group Z
mit Z = lineares oder verzweigtes Cr bis C|0-Alkyl, A H oder eine Gruppe Ri-CO-with Z = linear or branched C r to C | 0 -alkyl, AH or a group Ri-CO-
mit Ri=C,- bis C18-Alkylwith Ri = C, - to C 18 -alkyl
und
η 0, 1 oder 2.and
η 0, 1 or 2.
Diese Verbindungen sind z. B. Zwischenprodukte bei der Herstellung von Piparidinoalkylphenothiaziaen der FormelThese connections are e.g. B. Intermediates the production of Piparidinoalkylphenothiaziaen der formula
O —CH2-(CH2),,-CH2-Ο —ΑO —CH 2 - (CH 2 ) ,, - CH 2 -Ο —Α
Das Verfahren zur Herstellung der erfindungsgemäßen Verbindungen der Formel I ist gekennzeichnet durchThe process for the preparation of the compounds of the formula I according to the invention is indicated by
— Umsetzung eines cyclischen Acetals des N-Benzylpiperidons der Formel- Implementation of a cyclic acetal of N-benzylpiperidone the formula
C6H5-CH2-NC 6 H 5 -CH 2 -N
CH2 CH 2
CH2-CH-CH2-YCH 2 -CH-CH 2 -Y
mit X wie oben und Y = CI oder Br umgesetzt.implemented with X as above and Y = CI or Br.
O —CH2 O -CH 2
mit η wie obenwith η as above
in wasserfreiem Medium,in an anhydrous medium,
(a) wenn TJ gleich H ist,(a) if TJ equals H,
mit Lithiumalanat in Gegenwart einer Lewissäure oder,with lithium alanate in the presence of a Lewis acid or,
(b) wenn TJ gleich Z, d. h. gleich Ci- bis do-Alkyl ist,(b) if TJ is Z, ie is Ci- to do-alkyl,
mit einem Alkylmagnesiumhalcgenid der Formelwith an alkyl magnesium halide of the formula
Z-Mg-XZ-Mg-X
mit Z = lineares oder verzweigtes Cr bis Cio-Alkyl und X = CI, Br oder Jwith Z = linear or branched Cr bis Cio-alkyl and X = CI, Br or J
zu einer Verbindung der Formel Iato a compound of the formula Ia
/—\ / C6H5-CH2-N χ / - \ / C 6 H 5 -CH 2 -N χ
O —CH2-(CH2),,-CH2-OHO -CH 2 - (CH 2 ) ,, - CH 2 -OH
mit Z' und η wie oben,with Z 'and η as above,
die gegebenenfalls mit einem Säurechloridoptionally with an acid chloride
Ri-CO-CIRi-CO-CI
mit Ri wie obenwith Ri as above
zu einer Verbindung der Formel Ibto a compound of the formula Ib
CiH5-CH2-NCiH 5 -CH 2 -N
mit Ri, Z' und η wie oben
umgesetzt wird,with Ri, Z 'and η as above
is implemented,
Z'Z '
O — CH2-(CH2),,- CH2- O — CO — R1 O - CH 2 - (CH 2 ) ,, - CH 2 - O - CO - R 1
sowie erforderlichenfallsand if necessary
— Hydrierung der Verbindung der Formel la bzw. Ib in Gegenwart eines Palladiumkatalysators zur entsprechenden Verbindung der Formel Ia' bzw. Ib'.- Hydrogenation of the compound of formula la or Ib in the presence of a palladium catalyst to the corresponding compound of formula Ia 'or Ib '.
Η —ΝΗ —Ν
Z'Z '
0-CHj-(CH3),,-CH3-OH (Ia')0-CHj- (CH 3 ) ,, - CH 3 -OH (Ia ')
Η —ΝΗ —Ν
Z'Z '
O —CH3-(CH2),,-CH3-O —CO —R, (Ib')O —CH 3 - (CH 2 ) ,, - CH 3 -O —CO —R, (Ib ')
Als Lewis-Säuren eignen sich etwa Aluminiumchlorid oder Zinkchlorid.Aluminum chloride or zinc chloride, for example, are suitable as Lewis acids.
Bevorzugt wird bei der Herstellung der erfindungsgemäßen Verbindungen wie folgt verfahren:The preferred procedure for the preparation of the compounds according to the invention is as follows:
Im Fall a)In case a)
Das cyclische Acetal des Benzylpiperidons wird zu einer in wasserfreiem Äther suspendierten Mischung von Lithiumalanat und Aluminiumchlorid gegeben und bei einer Temperatur zwischen 15° C und der Siedetemperatur des Reaktionsgemischs 1 bis 5 h lang umgesetzt. Danach wird der gebildete Komplex durch Zugabe von Wasser hydrolysiert, das Reaktionsgemisch mit Natriumhydroxid alkalisch gemacht und die Verbindung der Formel Ia mit Z' = H in üblicher Weise ei wa durch Extraktion und nachfolgende Destillation isoliert.The cyclic acetal of benzylpiperidone becomes added to a mixture of lithium alanate and aluminum chloride suspended in anhydrous ether and at a temperature between 15 ° C and the boiling point of the reaction mixture reacted for 1 to 5 hours. After that, the complex formed is through Adding water hydrolyzes the reaction mixture with sodium hydroxide and hydrolyzes the compound of the formula Ia with Z '= H isolated in the usual way ei wa by extraction and subsequent distillation.
Im Fall b)In case b)
Es wird zunächst eine Alkylmagnesiumverbindung der Formel Z-Mg-X mit Z = C,- bis do-Alkyl und X = Br durch Umsetzung des entsprechenden Alkylbromids mit Magnesium in einem Lösungsmittel wie wasserfi eiern Äther in Gegenwart von Jod hergestellt. Zu diesem Alkylmagnesiumbromid wird dann das in einem wasserfreien Lösungsmittel wie Benzol gelöste cyclische Acetal des Benzylpiperidons zugegeben; nach Abtrennung des ersten Lösungsmittels wird das Gemisch 10 bis 24 h am Rückfluß gehalten. Die Lösung wird dann abgekühlt und der gebildete Komplex mit einer wäßrigen gesättigten Ammoniumchloridlösung hydrolysiert. Die erhaltene Verbindung der Formel la mit Z' = Z wird in üblicher Weise etwa durch Extraktion und nachfolgende Destillation isoliert.First there is an alkylmagnesium compound of the formula Z-Mg-X with Z = C, - to do-alkyl and X = Br by reaction of the corresponding alkyl bromide made with magnesium in a solvent such as water-free ether in the presence of iodine. This alkyl magnesium bromide is then dissolved in an anhydrous solvent such as benzene cyclic acetal of benzylpiperidone added; after the first solvent has been separated off, the The mixture was refluxed for 10 to 24 hours. The solution is then cooled and the complex formed with an aqueous saturated ammonium chloride solution hydrolyzed. The resulting compound of the formula la with Z '= Z is in the usual way, for example by extraction and subsequent distillation isolated.
Die Hydrierung der Produkte der Formeln Ia und Ib mit Wasserstoff in Gegenwart eines Palladiumkatalysators erfolgt vorzugsweise durch Suspendieren der Verbindungen in absolutem Äthanol und anschließendes Rühren oder Schütteln dieser Suspension in einer Wasserstoffatmosphäre in Gegenwart von auf Kohle abgeschiedenem Palladium (Palladiumgehalt zwischen 1% und 10%). Dabei wird vorzugsweise bei einem Wasserstoffdruck zwischen Atmosphärendruck und IO bar und bei einer Temperatur zwischen 30 und 700C hydriert. Nach Absorption der theoretischen Menge Wasserstoff wird der Katalysator von der organischen Phase abfiltriert und die Verbindung der Formel Ic daraus in üblicher Weise isoliert. Hierzu kann beispielsweise das Äthanol abgetrennt und der Rückstand rektifiziert werden.The hydrogenation of the products of the formulas Ia and Ib with hydrogen in the presence of a palladium catalyst is preferably carried out by suspending the compounds in absolute ethanol and then stirring or shaking this suspension in a hydrogen atmosphere in the presence of palladium deposited on carbon (palladium content between 1% and 10%) . In this case, preferably hydrogenated at a hydrogen pressure between atmospheric pressure and IO bar and at a temperature between 30 and 70 0 C. After the theoretical amount of hydrogen has been absorbed, the catalyst is filtered off from the organic phase and the compound of the formula Ic is isolated therefrom in the customary manner. For this purpose, for example, the ethanol can be separated off and the residue rectified.
Die Umsetzung ο .r Verbindung der Formel hi milThe implementation ο .r compound of the formula hi mil
2» dem Säurechlorid R,-CO—Cl wird vorzugsweise wie folgt durchgeführt: 2 » the acid chloride R, -CO — Cl is preferably carried out as follows:
Die Verbindung der Formel Ia und Triethanolamin werden in Benzol gelöst und ropfenweise mit dem Säurechiorid versetzt, wobei das Reaktionsgefäb in einem Eisbad gehalten wird. Die Lösung wird dann 24 bis 48 h lang bei Raumtemperatur belassen und der gebildete Niederschlag anschließend durch Absaugen bzv. Abzentrifugieren abgetrennt. Das erhaltene benzolische Filtrat wird mit einer wäßrigen Natriumhydrogencarbonatlösung und dann mit Wasser gewaschen. Man dampft schließlich die benzolische Lösung ein und destilliert den Rückstand. Die so erhaltene Verbindung der Formel Ib wird aus dem Destillat isoliert.The compound of the formula Ia and triethanolamine are dissolved in benzene and mixed in drops with the Acid chloride is added while the reaction vessel is kept in an ice bath. The solution then becomes 24 Leave at room temperature for up to 48 hours and then remove the precipitate formed by suction bzv. Separated by centrifugation. The benzene filtrate obtained is treated with an aqueous sodium hydrogen carbonate solution and then washed with water. Finally, the benzene is steamed Solution and distilled the residue. The compound of formula Ib obtained in this way is from the Distillate isolated.
Die beim erfindungsgemäßen Verfahren eingesetzten cyclischen Acetale des N-Benzylpiperidons können, soweit sie nicht bekannt sind, durch Umsetzung eines entsprechenden Diols der FormelThe cyclic acetals of N-benzylpiperidone used in the process according to the invention can if they are not known, by reaction of a corresponding diol of the formula
HO-CH2-(CH3)„-CH2-OHHO-CH 2 - (CH 3 ) "- CH 2 -OH
mit η wie obenwith η as above
mit l-Benzylpiperidon-(4) in Gegenwart von Chlorwasserstoffsäure nach an sich bekannten Verfahren hergestellt werden.with l-benzylpiperidone- (4) in the presence of hydrochloric acid be produced by methods known per se.
Herstellung von 2-(Piperidyl-4.oxy)-äthanol a) 2-(l-Benzylpiperidyl-4-oxy)-äthanolProduction of 2- (piperidyl-4.oxy) ethanol a) 2- (1-Benzylpiperidyl-4-oxy) ethanol
In einen 2-l-Dreihalskolben werden 106,8 g (0,8 mol) Aluminiumchlorid gegeben und dann unter guter Kühlung mit 800 ml wasserfreiem Äther versetzt. Nach 30 min Rühren wird eine Suspension von 7,6 g (0.2 mol) Lithiumalanat in 200 ml wasserfreiem Äther zugegeben.106.8 g (0.8 mol) of Given aluminum chloride and then mixed with 800 ml of anhydrous ether with good cooling. To Stirring for 30 min, a suspension of 7.6 g (0.2 mol) of lithium alanate in 200 ml of anhydrous ether is added.
Nach 30 min Rühren wird tropfenweise eine Lösung Vjr 93,2 g (0,4 moi) e-Benzyl-l^-dioxa-S-aza-spiro-[4,5]-decan in 400 ml wasserfreiem Äther zugesetzt. Nach Beendigung der Zugabe wird noch 2 h lang bei Raumtemperatur weiter gerührt. Dann wird s'.ark gekühlt und sehr vorsichtig I I Wasser hinzugegeben; das Gemisch wird danach durch Zugabe von (j0 g Natriumhydrcxidplätzchen alkalisch gemacht.After stirring for 30 minutes, a solution of 93.2 g (0.4 mol ) of e-benzyl-l ^ -dioxa-S-aza-spiro [4.5] decane in 400 ml of anhydrous ether is added dropwise. After the addition is complete, stirring is continued for a further 2 hours at room temperature. Then it is chilled very carefully and water is added very carefully; the mixture is then made alkaline by the addition of ( 10 g of sodium hydroxide biscuits.
Man dekantiert den Äther ab und extrahiert die wäßrige Phase erneut mit Äther. Nach den Trocknen der vereinigten ätherischen Phasen wird der Äther abgedampft und der Rückstand destilliert. Man erhält so 6Jg 2-(1-Benzylpiperidyl-4-oxy)-äthanol in Form eines klaren Öls: Austeilte 67%.The ether is decanted off and the aqueous phase is extracted again with ether. After drying the combined ethereal phases, the ether is evaporated and the residue is distilled. You get so 6Jg 2- (1-benzylpiperidyl-4-oxy) ethanol in the form of a clear oil: distributed 67%.
Kp= 140X70,133 mbar.Kp = 140X70.133 mbar.
η =--1.633. η = - 1.633.
Analyse:
Summenlormel: CuAnalysis:
Sum formula: Cu
Berechnet: N 6,0%;Calculated: N 6.0%;
gefunden: N 5.9%.found: N 5.9%.
b) 2-(Piperidyl-4-oxy)-äthanolb) 2- (piperidyl-4-oxy) ethanol
48 g (0,204 mol) 2-(l-Benzylpiperidyl-4-oxy)-äthanol werden in 500 ml absolutem Äthanol gelöst. Die Lösung wird bei 500C in Gegenwart von 5 g Palladiumkohle (5%) mit Wasserstoff hydriert, bis die theoretische Menge Wasserstoff absorbiert ist. Der Katalysator wird dann abfiltriert, der Äthanol abgedampft und der Rückstand destilliert. Man erhält so 22 g (74%) 2-(Piperidyl-4-oxy)-äthanol in Form eines farblosen Öls, das beim Abkühlen kristallisiert.48 g (0.204 mol) of 2- (l-benzylpiperidyl-4-oxy) ethanol are dissolved in 500 ml of absolute ethanol. The solution is hydrogenated with hydrogen at 50 ° C. in the presence of 5 g of palladium carbon (5%) until the theoretical amount of hydrogen has been absorbed. The catalyst is then filtered off, the ethanol is evaporated and the residue is distilled. This gives 22 g (74%) 2- (piperidyl-4-oxy) ethanol in the form of a colorless oil which crystallizes on cooling.
Kp=1IO°C/O,O133mbar.Kp = 110 ° C / 0.133 mbar.
Das Produkt wird aus Cyclohexan umkristallisiert.The product is recrystallized from cyclohexane.
Fp = 7 T C.Fp = 7 T C.
Analyse:Analysis:
Stimmenformel: C:HnNO>Voice formula: C: ENT>
Berechnet: C 57.9. H 10.4. N 9.7%:Calculated: C 57.9. H 10.4. N 9.7%:
gefunden: C 57.5. H 10.5. N 9.8%.found: C 57.5. H 10.5. N 9.8%.
c) 8-Benzyl-l.4-dioxa-8-aza-spiro-[4.5]-decanc) 8-Benzyl-1.4-dioxa-8-aza-spiro- [4.5] -decane
Das als Aiisgangsmaterial eingesetzte cyclische Acetal kann wie folgt erhalten werden:The cyclic used as starting material Acetal can be obtained as follows:
In einem 2-l-Dreihalskolben mit Gaseinleitungsrohr und Dean-Stark-Aufsatz werden 68.3 g (I.I mol) Äthylenglycol und I I wasserfreies Benzol gemischt.In a 2 l three-necked flask with a gas inlet tube and Dean-Stark attachment, 68.3 g (I.I mol) ethylene glycol and I I anhydrous benzene are mixed.
Das Gemisch wird zur Abtrennung von ggf. anwesendem Wasser /um Sieden erhitzt und dann mit 189 g (1 mol) I-Ben/> lpiperidon-(4) versetzt. Die Mischung wird dann weiter /um Sieden erhitzt, wobei in die Lösung ein Strom trockenen gasförmigen Chlorwasserstoffs eingeleitet wird, bis 18 ml (1 mol) Wasser abgetrennt sind, was etwa 6 h dauert.The mixture is heated to the boil to separate any water that may be present and then with it 189 g (1 mol) of I-Ben /> lpiperidon- (4) are added. the The mixture is then further heated to boiling, with in the solution is passed in a stream of dry gaseous hydrogen chloride until 18 ml (1 mol) of water are separated, which takes about 6 hours.
Nach dem Abkühlen wird der erhaltene Niederschlag abgetrennt, mit Benzol gewaschen und dann aus absolutem Äthanol umkristallisiert. Man erhält so 213 g 8-Benzyl-l.4-dioxa-P azaspiro-[4.5]-decanhydrochlorid in Form vor weißen Kristallen. Fp = 262cC: Ausbeute 79%.After cooling, the precipitate obtained is separated off, washed with benzene and then recrystallized from absolute ethanol. This gives 213 g of 8-benzyl-1,4-dioxa-P azaspiro- [4.5] decane hydrochloride in the form of white crystals. Mp = 262 c C: yield 79%.
Diese Verbindung wird in 1 I wasserfreiem Äther suspendiert, durch den 4 h lang ein Ammoniakstrom geleitet wird. Der zurückbleibende Feststoff wird abfiltriert und der Äther abgedampft. Man erhalt 178 g 8-Benzyl-1.4-dio\a-8-aza-spiro-[4.5]-decan in Form eines hell-bernsteinfarbenen Öls. das im Kühlschrank kristallisiert. Fp < 50 C: Ausbeute 76%. bezogen auf 1 -Benzylpipcridon-(4).This compound is suspended in 1 l of anhydrous ether, through which a stream of ammonia is passed for 4 hours is directed. The remaining solid is filtered off and the ether evaporated. 178 g are obtained 8-Benzyl-1,4-dio \ a-8-aza-spiro- [4.5] -decane in the form of a light amber colored oil. that in the fridge crystallized. Mp <50 C: yield 76%. based on 1 -Benzylpipcridon- (4).
Analyse:Analysis:
Summenformel: C ^H jNO;Molecular Formula: C ^ H jNO;
Berechnet: N 6.0%:Calculated: N 6.0%:
gefunden: N 6.0°r>.found: N 6.0 ° r>.
B e i s ρ i e ! 2B e i s ρ i e! 2
Herstellung von 3-(Pipendyl-4-o\y)-propanol
a) 3-(l-Benz>lpiperid\I-4-oxy)-propanolProduction of 3- (Pipendyl-4-o \ y) propanol
a) 3- (l-Benz> lpiperid \ I-4-oxy) propanol
Bei gleicher Arbeitsweise wie in Beispiel l(a). jedoch unter Verwendung von 98.8 g (0.4 mol) 9-Benzyl-1.5-dioxa-9-aza-spiro-[5.5]-undecan. erhält man 48 g3-(1-Benzylpiperidyl-4-ox\-propanol in Form eines hellen Öls.With the same procedure as in example l (a). however, using 98.8 g (0.4 mol) of 9-benzyl-1.5-dioxa-9-aza-spiro- [5.5] -undecane. 48 g of 3- (1-benzylpiperidyl-4-ox-propanol are obtained in the form of a pale oil.
.nusucuic to-■■!'..nusucuic to- ■■! '.
Kp=16O"CO.133mbar.
π =1.531.Kp = 160 "CO. 133 mbar.
π = 1,531.
Analyse:Analysis:
Summenformel: C15H2JNO2Molecular formula: C15H2JNO2
Berechnet: N 5,6%;Calculated: N 5.6%;
gefunden: N 5.7%.found: N 5.7%.
b) 3-(Piperidyl-4-oxy)-propanolb) 3- (piperidyl-4-oxy) propanol
Bei gleicher Arbeitsweise wie in Beispiel l(b), aber unter Verwendung von 47,5g (0,19 mol) 3-(l-Benzylpiperidyl-4-oxy)-propanol erhält man 22,2 g 3-(Piperidyl-4-oxy)-propanol in Form eines farblosen Öls. Ausbeute 73%.Using the same procedure as in Example 1 (b), but using 47.5 g (0.19 mol) of 3- (1-benzylpiperidyl-4-oxy) propanol 22.2 g of 3- (piperidyl-4-oxy) propanol are obtained in the form of a colorless oil. Yield 73%.
Kp=112*C/0,0133mbar.Kp = 112 * C / 0.0133 mbar.
η =1.488. η = 1,488.
Analyse:Analysis:
Summenformel: C11H17NO2Molecular formula: C11H17NO2
Berechnet: C 60,3. H 10,8, N 8.8%;Calculated: C 60.3. H 10.8, N 8.8%;
gefunden: C 60.4. H 10.7. N 9.0%.found: C 60.4. H 10.7. N 9.0%.
c) 9-Benzyl-1.5-dioxa-9-aza-spiro-[5.5j-undecanc) 9-Benzyl-1,5-dioxa-9-aza-spiro- [5.5j-undecane
Diese Verbindung kann wie in Beispiel l(c) erhalten werden, wobei 83,6 g (1.1 mol) Propandiol-(1.3) verwendet wird. Man erhält 180g g-Benzyl-l.S-dioxa-9-aza-spiro-[5,5]-undecan in Form eines hell-bernsteinfarbenen Öls. das im Kühlschrank kristallisiert.This compound can be obtained as in Example 1 (c) using 83.6 g (1.1 mol) of propanediol- (1.3) will. 180 g of g-benzyl-IS-dioxa-9-aza-spiro- [5,5] -undecane are obtained in the form of a light amber-colored oil. that crystallizes in the refrigerator.
Fp <50°C; Ausbeute 73%. bezogen auf I-Benzylpipericion-(4). Mp <50 ° C; Yield 73%. based on I-Benzylpipericion- (4).
Analyse:Analysis:
1,1 Summenformel:
Berechnet
gefunden:1.1 Molecular formula:
Calculated
found:
N 5.7%:
N 5.6%.N 5.7%:
N 5.6%.
Γι Herstellung von 4-(Piperidyl-4-oxy)-butanolΓι Production of 4- (piperidyl-4-oxy) butanol
a) 4-(N-Benzylpiperidyl-4-oxy)-butanola) 4- (N-Benzylpiperidyl-4-oxy) butanol
Bei gleicher Arbeitsweise wie in Beispiel l(a). aber unter Verwendung von 110g (0.421 mol) 10-Benzyl-4,i
1.6-dioxa-I0-aza-spiro-[5.6]-dodecan. erhält man 71.5g 4-(N-Benzylpiperidyl-4-oxy)-butanol in Form eines
klaren Öls: Ausbeute 65%.
Kp=l65°C/O.O67mbar.With the same procedure as in example l (a). but using 110 g (0.421 mol) of 10-benzyl-4, i 1.6-dioxa-10-aza-spiro- [5.6] -dodecane. 71.5 g of 4- (N-benzylpiperidyl-4-oxy) butanol are obtained in the form of a clear oil: yield 65%.
Kp = l65 ° C / O.O67 mbar.
Analvse:Analvse:
Summenformel: CieH^NO:Molecular formula: CieH ^ NO:
Berechnet: N 5.3%:Calculated: N 5.3%:
gefunden: N 5.6%.found: N 5.6%.
b) 4-(Piperidyl-4-oxy)-butanolb) 4- (piperidyl-4-oxy) butanol
Bei gleicher Arbeitsweise wie in Beispiel l(b* aberWith the same working method as in example 1 (b * but
unter Verwendung von 82.9 g (0.314 mol) 4-(N-Benzylpiperidyl-4-oxy)-butanol. erhält man 34.1 g4-(Piperidyl-4-oxy)-butanol in Form eines farblosen Öls: Ausbeuteusing 82.9 g (0.314 mol) 4- (N-benzylpiperidyl-4-oxy) -butanol. 34.1 g of 4- (piperidyl-4-oxy) butanol are obtained in the form of a colorless oil: yield
v, 61%'.v, 61% '.
Kp=120=C/0.067mbar.Kp = 120 = C / 0.067mbar.
η =1.486. η = 1,486.
Analyse:
r0 Summenformel: C^HiciNO:Analysis:
r0 Molecular formula: C ^ HiciNO:
Berechnet: C 62.4. H 11.1. N 8.1%:
gefunden: C 61.9. H 11.2. N 8.0%.Calculated: C 62.4. H 11.1. N 8.1%:
found: C 61.9. H 11.2. N 8.0%.
c) 10- Benzyl-1.6-dioxa-10-aza-spiro-[5.6]-dodecan
ri Diese Verbindung kann wie in Beispiel l(c) erhalten
nVIUVII. iy\JXJ^l ^t .\J ζ. \V.V-f lllUlj UUtUIlUlUl \·*'/ »W"
wendet werden. Man erhält 139.6 g lO-Benzyl-l.ö-dioxy-10-aza-spiro-[5.6]-dodecan
in Form eines klaren, bern-c) 10-benzyl-1.6-dioxa-10-aza-spiro- [5.6] -dodecane
ri This compound can be obtained as in Example l (c) nVIUVII. iy \ JXJ ^ l ^ t. \ J ζ. \ VV-f lllUlj UUtUIlUlUl \ * * '/ "W" are obtained. 139.6 g of 10-benzyl-l-dioxy-10-aza-spiro- [5.6] -dodecane are obtained in the form of a clear, amber-
steinfarbenen Öls. das im Kühlschrank kristallisiert. Momentanschmelzpunkt: F. = 52°C; Ausbeute 92%, bezogen auf l-Benzylpiperidon-(4).stone-colored oil. that crystallizes in the refrigerator. Instant melting point: m.p. = 52 ° C; Yield 92%, based on l-benzylpiperidone- (4).
Analyse:Analysis:
Summenformel: Cis^iNO?Molecular Formula: Cis ^ iNO?
Berechnet: N 5,4%;Calculated: N 5.4%;
Pfunden: N 5.2%.Pounds: N 5.2%.
Herstellung von 2-(Piperidyl-4-oxyVäthylacetat
a) 2-(N-Benzylpiperidyl-4-oxy)-äthylacetatProduction of 2- (piperidyl-4-oxy-ethyl acetate
a) 2- (N-Benzylpiperidyl-4-oxy) ethyl acetate
Zu einer Lösung von 47 g (0.2 mol) des gemäß Beispiel l(a) hergestellten 2-(l-Benzylpiperidyl-4-oxy)-äthanols und 20,2 g (0,2 mol) Triäthylamin in 300 ml Benzol gibt man tropfenweise unter Kühlung mit einem Eisbad auf 20°C 15.6 g (0,2 mol) Acetylchlorid. Man läßt das Reaktionsgemisch 48 h bei Raumtemperatur stehen und saugt oder zentrifugiert dann den gebildeten Niederschlag ab. Das benzolische Filtrat wird mit einer wäßrigen Natriumhydrogencarbonatlösung und dann mit Wasser gewaschen. Nach dem Trocknen und Eindampfen der benzolischen Lösung wird der Rückstand destilliert; man erhält 36,5 g 2-(N-Benzylpiperidyl-4-oxy)-äthylacetat in Form eines klaren Öls; Ausbeute 66%.To a solution of 47 g (0.2 mol) of the according to Example l (a) prepared 2- (l-benzylpiperidyl-4-oxy) ethanol and 20.2 g (0.2 mol) of triethylamine in 300 ml Benzene is added dropwise to 20 ° C. while cooling with an ice bath, 15.6 g (0.2 mol) of acetyl chloride. One lets the reaction mixture stand for 48 h at room temperature and then suck or centrifuge the formed Precipitation from. The benzene filtrate is with an aqueous sodium hydrogen carbonate solution and then washed with water. After drying and evaporation of the benzene solution, the residue is distilled; 36.5 g of 2- (N-benzylpiperidyl-4-oxy) ethyl acetate are obtained in the form of a clear oil; Yield 66%.
Kp= 160- 170?C/0.133 mbar.Kp = 160-170 ? C / 0.133 mbar.
π =1.512.π = 1.512.
Analyse:Analysis:
S.immenformel: CibH.^NO)Voice formula: CibH. ^ NO)
Berechnet: C 69.3. H 8,4. N 5,1%;Calculated: C 69.3. H 8.4. N 5.1%;
gefunden: C 68,7, H 8,4, N 4,9%.found: C 68.7, H 8.4, N 4.9%.
b) 2-(Piperidyl-4-oxy)-äthylacetatb) 2- (piperidyl-4-oxy) ethyl acetate
36,4 g (0.131 mol) 2-(N-Benzylpiperidyl-4-oxy)-äthylacetat werden in 200 ml absolutem Äthanol gelöst. Dann wird bei 50°C in Gegenwart von 3,5 g Palladiumkohle (5%) hydriert, bis die theoretische Menge Wasserstoff absorbiert ist.36.4 g (0.131 mol) of 2- (N-benzylpiperidyl-4-oxy) ethyl acetate are dissolved in 200 ml of absolute ethanol. then is hydrogenated at 50 ° C in the presence of 3.5 g of palladium carbon (5%) until the theoretical amount of hydrogen is absorbed.
Danach wird der Katalysator abfiltriert, das Äthanol abgedampft und der Rückstand destilliert. Man erhält so 18,2 g 2-(Piperidyl-4-oxy)-äthylacetat in Form eines klaren Öls: Ausbeute 74%.The catalyst is then filtered off, the ethanol is evaporated off and the residue is distilled. You get so 18.2 g of 2- (piperidyl-4-oxy) ethyl acetate in the form of a clear oil: yield 74%.
Kp= 102° C/0.133 mbar.Kp = 102 ° C / 0.133 mbar.
π) =1,4665. π) = 1.4665.
Analyse:Analysis:
Summenformel: C9H1-NO3Molecular formula: C9H1-NO3
Berechnet: C 57,7, H 9,2, N 7.5%;Calculated: C 57.7, H 9.2, N 7.5%;
gefunden: C 57.5. H 9,2, N 7.5%.found: C 57.5. H 9.2, N 7.5%.
Beispiel 5
Herstellung von 2-(Piperidyl-4-oxy)-äthyloctanoatExample 5
Production of 2- (piperidyl-4-oxy) ethyloctanoate
Zu einer Lösung von 47 g (0,2 mol) des nach Beispiel l(a) hergestellten 2-(l-Benzylpiperidyl-4-oxy)- bo äthanols und 20.2 g (0,2 mol) Triäthylamin in 300 ml Benzo! gibt man tropfenweise unter Kühlung mit einem Eisbad auf 200C 32,4 g (0.2 mol) Octanoyichlorid. Das Reaktionsgemisch wird 24 h lang bei Raumtemperatur stehengelassen und der gebildete Niederschlag dann abgesaugt oder abzentrifugiert. Das gesammelte benzolische Filtrat wird mit einer wäßrigen Natriumhydrogencarbonatlösung und dann mit Wasser gewaschen. Nach Trocknen und Eindampfen der benzolischen Lösung wird der erhaltene Rückstand in 300 ml absolutem Äthanol gelöst. Dann wird bei 50°C in Gegenwart von 4,5 g Palladiumkohle (5%) hydriert, bis die theoretische Menge Wasserstoff absorbiert ist. Nach Abfiltrieren des Katalysators wird das Äthanol abgedampft und der Rückstand destilliert. Man erhält 35,5 g 2-(Piperidyl-4-oxy)-äthyloctanoat in Form eines klaren Öls; Ausbeute 64%.To a solution of 47 g (0.2 mol) of the 2- (l-benzylpiperidyl-4-oxy) prepared according to Example l (a) - bo ethanol and 20.2 g (0.2 mol) of triethylamine in 300 ml of benzo! is added dropwise while cooling with an ice bath to 20 0 C 32.4 g (0.2 mol) Octanoyichlorid. The reaction mixture is left to stand for 24 hours at room temperature and the precipitate formed is then filtered off with suction or centrifuged. The collected benzene filtrate is washed with an aqueous sodium hydrogen carbonate solution and then with water. After the benzene solution has been dried and evaporated, the residue obtained is dissolved in 300 ml of absolute ethanol. The mixture is then hydrogenated at 50 ° C. in the presence of 4.5 g of palladium carbon (5%) until the theoretical amount of hydrogen has been absorbed. After filtering off the catalyst, the ethanol is evaporated and the residue is distilled. 35.5 g of 2- (piperidyl-4-oxy) ethyloctanoate are obtained in the form of a clear oil; Yield 64%.
Kp= 150- 156°C/0.133 mb?r.Bp = 150-156 ° C / 0.133 mb? R.
n-: =1,464. n-: = 1.464.
Analyse:Analysis:
Summenformel: Ο,Κ'ίΝΟ)Molecular formula: Ο, Κ'ίΝΟ)
Berechnet: C 66,4. H 10,8. N 5.2%;Calculated: C 66.4. H 10.8. N 5.2%;
gefunden: C 66.0. H 10.7. N 5.3%.found: C 66.0. H 10.7. N 5.3%.
Herstellung von 2-(4-Methylpiperidyl-4-oxy)-äthanol
a) 2-(N-Benzyl-4-methylpiperidyl-4-oxy)-äthanolProduction of 2- (4-methylpiperidyl-4-oxy) ethanol
a) 2- (N-Benzyl-4-methylpiperidyl-4-oxy) ethanol
In einem Kolben werden 150 ml Äther vorgelegt, der auf etwa — IO°C abgekühlt und mit 40 g Methylbromid versetzt und gemischt wird.150 ml of ether are placed in a flask, which is cooled to about -10 ° C. and mixed with 40 g of methyl bromide is added and mixed.
In einen anderen Kolben gibt man 9,6 g Magnesiumspäne, 50 ml Äther und einen Jodkristall und versetzt dieses Gemisch tropfenweise mit der Methylbromidlösung. Nach Beendigung der Zugabe wird eine Lösung von 46,6 g 8-Benzyl-1.4-dioxa-8-aza-spiro-[4,5]-decan in 1 I wasserfreiem Benzol zugegeben.9.6 g of magnesium turnings, 50 ml of ether and an iodine crystal are placed in another flask, and the methyl bromide solution is added dropwise to this mixture. When the addition is complete, a solution of 46.6 g of 8-benzyl-1,4-dioxa-8-aza-spiro [4.5] decane in 1 l of anhydrous benzene is added.
Nach dem Abdampfen des Äthers wird das Gemisch 16 h am Rückfluß gehalten. Danach wird die erhaltene Lösung abgekühlt und mit einer gesättigten Ammoniumchloridlösung hydrolysiert. Das Benzol wird abdekantiert und die wäßrige Phase mit Äther extrahiert. Man trocknet die organische Phase über Natriumsulfat, dampft die Lösungsmittel im Vakuum ab und rektifiziert den Rückstand unter vermindertem Druck. Man erhält so 42,8 g 2-(N-Benzyl-4-methylpiperidyl-4-oxy)-äthanol in Form eines farblosen Öls.After the ether has evaporated, the mixture is refluxed for 16 h. After that, the received Solution cooled and hydrolyzed with a saturated ammonium chloride solution. The benzene is decanted off and the aqueous phase extracted with ether. The organic phase is dried over sodium sulfate, the solvents are evaporated off in vacuo and the residue is rectified under reduced pressure. You get so 42.8 g of 2- (N-benzyl-4-methylpiperidyl-4-oxy) ethanol in the form of a colorless oil.
Kp= 136-140°C/0,133 mbar.Bp = 136-140 ° C / 0.133 mbar.
n? = 1,527.n? = 1.527.
Analyse:Analysis:
Summenformel: C5H21NO2 (M = 249.3)Molecular formula: C5H21NO2 (M = 249.3)
Berechnet: C 72.25. H 9.30. N 5.62%;Calculated: C 72.25. H 9.30. N 5.62%;
gefunden: C 72,4. H 9.2, N 5.9%.found: C 72.4. H 9.2, N 5.9%.
b) 2-(4-Methylpiperidyl-4-oxy)-äthanolb) 2- (4-methylpiperidyl-4-oxy) ethanol
51,5 g des nach a) erhaltenen 2-(N-Benzy!-4-methylpiperidyl-4-oxy)-äthanols werden in 500 ml absolutem Äthanol gelöst und bei 50°C in Gegenwart von 5 g Palladiumkohle (5%) hydriert, bis die theoretische Menge Wasserstoff absorbiert ist. was etwa 3,5 h erfordert. Nach dem Abfiltrieren des Katalysators wird das Äthanol abgedampft und der Rückstand unter vermindertem Druck rektifiziert. Man erhält so 24 g 2-(4-Methylpiperidyl-4-oxy)-äthanol in Form eines farblosen Öls.51.5 g of the 2- (N-benzy! -4-methylpiperidyl-4-oxy) ethanol obtained according to a) are dissolved in 500 ml of absolute ethanol and at 50 ° C in the presence of 5 g Palladium carbon (5%) hydrogenated until the theoretical amount of hydrogen is absorbed. which is about 3.5 h requires. After filtering off the catalyst, the ethanol is evaporated off and the residue under reduced pressure Pressure rectified. This gives 24 g of 2- (4-methylpiperidyl-4-oxy) ethanol in the form of a colorless Oil.
Kp = 80—86°C/0.0133 mbar.Kp = 80-86 ° C / 0.0133 mbar.
ri;= 1.481. ri; = 1,481.
Analyse:Analysis:
Summenformel: C3Hi-NO2 (M = 159.2)Molecular formula: C 3 Hi-NO 2 (M = 159.2)
Berechnet: C 6034. H 10.76%:Calculated: C 6034. H 10.76%:
gefunden: C 59.6. H 10.5%.found: C 59.6. H 10.5%.
Herstellung von 2-(4-Äthylpiperidyl-4-oxy)-äthanol
a) 2-(N-BenzyI-4-äthylpiperidyl-4-oxy)-äthanolProduction of 2- (4-ethylpiperidyl-4-oxy) -ethanol
a) 2- (N-BenzyI-4-ethylpiperidyl-4-oxy) ethanol
In einem Kolben werden 19,2 g Magnesium und 100 ml Äther vorgelegt und dann am Rückfluß tropfenweise mu 87,5 g Äthylbromid in 100 ml Äther versetzt. Die Zugabe erfolgt während etwa 30 min.19.2 g of magnesium and 100 ml of ether are placed in a flask and then refluxed 87.5 g of ethyl bromide must be added dropwise to 100 ml of ether. The addition takes place over about 30 minutes.
Nach dem Abkühlen werden 46,6 g 8-Benzyl-1.4-dioxa-8-aza-spiro-[4,5]-decan in 250 ml Benzol hinzugegeben. Man verdampft den Äther, gibt 250 ml Benzol hinzu und hält das Gemisch 20 h lang am Rückfluß. Danach wird das Reaktionsgemisch abgekühlt und mit einer gesättigten Ammoniumchloridlösung hydrolysiert. Dann wird die benzolische Phase abdekantiert und die wäßrige Phase mit Methylenchlorid extrahiert; die vereinigten organischen Phasen werden mit Wasser bis zur Neutralität gewaschen und über Natriumsulfat getrocknet; nach dem Abdampfen der Lösungsmittel unter vermindertem Druck wird der Rückstand rektifiziert. Man erhält so 37,6 g 2-(N-Benzyl-4-äthyl-piperidyl-4-oxy)-äthanol in Form eines farblosen Öls.After cooling, 46.6 g of 8-benzyl-1,4-dioxa-8-aza-spiro [4.5] decane are obtained added in 250 ml of benzene. The ether is evaporated off, 250 ml of benzene are added and the mixture is refluxed for 20 hours. The reaction mixture is then cooled and hydrolyzed with a saturated ammonium chloride solution. The benzene phase is then decanted off and the aqueous phase is extracted with methylene chloride; the combined organic phases are washed with water until neutral and over sodium sulfate dried; after the solvents have been evaporated off under reduced pressure, the residue is rectified. 37.6 g of 2- (N-benzyl-4-ethyl-piperidyl-4-oxy) -ethanol are obtained in the form of a colorless oil.
Kp= 152- 156°C/0,67 mbar.Kp = 152-156 ° C / 0.67 mbar.
Dieses Produkt wird ohne weitere Reinigung für die nachfolgende Stufe verwendet.This product is used for the next step without further purification.
b) 2-(4-Äthylpiperidyl-4-oxy)-äthanolb) 2- (4-Ethylpiperidyl-4-oxy) ethanol
37 g 2-(N-Benzyl-4-äthylpiperidyl-4-oxy)-äthanol werden in 300 ml absolutem Äthanol gelöst und bei 50°C in Gegenwart von 4 g Palladiumkohle (10%) hydriert, bis die theoretische Menge Wasserstoff absorbiert ist, was etwa 3 h erfordert.37 g of 2- (N-benzyl-4-äthylpiperidyl-4-oxy) ethanol are dissolved in 300 ml of absolute ethanol and in 50 ° C in the presence of 4 g of palladium carbon (10%) hydrogenated until the theoretical amount of hydrogen is absorbed, which takes about 3 hours.
Nach dem Abfiltrieren des Katalysators und Abdampfen des Äthanols wird der Rückstand rektifiziert. Man erhält so 19,2 g 2-(4-Äthylpiperidyl-4-oxy)-äthanol in Form eines farblosen Öls.After filtering off the catalyst and evaporation of the ethanol, the residue is rectified. 19.2 g of 2- (4-ethylpiperidyl-4-oxy) ethanol are thus obtained in the form of a colorless oil.
Kp= 102- 106°C/0,67 mbar.Kp = 102-106 ° C / 0.67 mbar.
Analyse:Analysis:
Summenformel: G)Hi1)NO2 (M = 173,26)Molecular formula: G) Hi 1 ) NO 2 (M = 173.26)
Berechnet: C 62,39, H 11.05, N 8,08%;Calculated: C 62.39, H 11.05, N 8.08%;
gefunden: C 62,4, H 10,8, N 8,0%.found: C 62.4, H 10.8, N 8.0%.
Beispiel 8
Herstellung von 2-(4-Propylpiperidyl-4-oxy)-äthanolExample 8
Production of 2- (4-propylpiperidyl-4-oxy) ethanol
a) 2-(N-Benzyl-4-propylpiperidyl-4-oxy)-äthanol
und dessen Hydrochlorida) 2- (N-Benzyl-4-propylpiperidyl-4-oxy) ethanol
and its hydrochloride
In einem Kolben werden 19,2 g Magnesium und 100 ml Äther vorgelegt und dann am Rückfluß tropfenweise mit 108 g Propylbromid in 250 ml Äther versetzt. 5i19.2 g of magnesium and 100 ml of ether are placed in a flask and then refluxed dropwise mixed with 108 g of propyl bromide in 250 ml of ether. 5i
Danach werden allmählich 46,6 g 8-Benzyl-1.4-dioxa-8-aza-spiro-[4,5]-decan in 500 ml Benzol zugegeben. Nach dem Abdampfen des Äthers wird das Reaktionsgemisch 24 h am Rückfluß gehalten. Then gradually 46.6 g of 8-benzyl-1,4-dioxa-8-aza-spiro [4.5] decane added in 500 ml of benzene. After the ether has evaporated, the reaction mixture is refluxed for 24 hours.
Die erhaltene Lösung wird abgekühlt und mit einer bo gesättigten Ammoniumchloridlösung hydrolysiert. Man dekantiert dann die benzolische Phase ab und extrahiert die wäßrige Phase mit Äther. Die organische Phase wird bis zur Neutralität mit Wasser gewaschen und über Natriumsulfat getrocknet. Nach dem Abdampfen der ni Lösungsmittel unter vermindertem Druck wird der Rückstand rektifiziert (Kp= 129GC/0.133mb^). Man erhält so 28 g 2-(N-Benzyl-4-propyipiperidyl-4-oxy)-äthanol in Form eines gelblichen Öls, das in 250 ml Äther gelöst wirr1 Zu der Lösung werden 13 ml einer 5 N-Lösung von Chlorwasserstoffsäure in Äther zugegeben; das erhaltene Hydrochlorid wird abgesaugt und aus Isopropanol umkristallisiert.The resulting solution is cooled and hydrolyzed with a b o saturated ammonium chloride solution. The benzene phase is then decanted off and the aqueous phase is extracted with ether. The organic phase is washed with water until neutral and dried over sodium sulfate. After the solvent has been evaporated off under reduced pressure, the residue is rectified ( boiling point = 129 G C / 0.133 MB ^). Are thus obtained 28 g of 2- (N-benzyl-4-propyipiperidyl-4-oxy) ethanol are of a yellowish oil, which confused dissolved in 250 ml ether 1 To the solution in the form of 13 ml of a 5 N solution of hydrochloric acid in Ether added; the hydrochloride obtained is filtered off with suction and recrystallized from isopropanol.
Nach dem Trocknen im Vakuum werden 12,9 g 2-(N-Benzyl-4-propyipiperidyl-4-oxy)-äthanol-hydiochlorid in Form von farblosen Kristallen gewonnen; Fp. 196° C.After drying in vacuo, 12.9 g of 2- (N-benzyl-4-propyipiperidyl-4-oxy) -ethanol hydrochloride are added obtained in the form of colorless crystals; Mp. 196 ° C.
Analyse:Analysis:
Summenformel·. C17H2SCINO2 (M = 313,87)Molecular Formula ·. C 17 H 2 SCINO 2 (M = 313.87)
Berechnet: C 65,06, H 8,99, N 4,46, Cl 11,30%;Calculated: C 65.06, H 8.99, N 4.46, Cl 11.30%;
gefunden: C 65,1, H 8,9, N 4,1, Cl 11,6%.found: C 65.1, H 8.9, N 4.1, Cl 11.6%.
b) 2-(4-Propylpiperidyl-4-oxy)-äthanolb) 2- (4-propylpiperidyl-4-oxy) ethanol
In 200 ml absolutem Äthanol werden 10,7 g 2-(N-Benzyl-4-propylpiperidyl-4-oxy)-äthanol gelöst, das aus dem unter a) erhaltenen Hydrochiorid durch Einieiien eines Ammoniakstroms in eine Suspension des Hydrochlorids in wasserfreiem Äther erhalten wurde, und bei 500C in Gegenwart von 1 g Palladiumkohlc (10%) hydriert, bis die theoretische Menge Wasserstoff absorbiert ist.10.7 g of 2- (N-benzyl-4-propylpiperidyl-4-oxy) ethanol are dissolved in 200 ml of absolute ethanol; was, and hydrogenated at 50 0 C in the presence of 1 g of palladium carbon (10%) until the theoretical amount of hydrogen is absorbed.
Nach dem Abfiltrieren des Katalysators wird das Äthanol abgedampft: man erhält 6,1 g 2-(4-Propylpiperidyl-4-oxy)-äthanol in Form von gelblichen Kristallen; Fp. 72° C.After the catalyst has been filtered off, the ethanol is evaporated off: 6.1 g of 2- (4-propylpiperidyl-4-oxy) ethanol are obtained in the form of yellowish crystals; Mp. 72 ° C.
Für die Analyse wird das Produkt aus Cyclohexan umkristallisiert. Das so erhaltene Produkt liegt in Form von weißen Kristallen vor, die in Chloroform löslich sind; Fp. 76°C.For the analysis, the product is recrystallized from cyclohexane. The product obtained in this way is in shape of white crystals soluble in chloroform; M.p. 76 ° C.
Analyse:Analysis:
Summenformel: CmH2INOj (M = 187,28)Molecular formula: CmH 2 INOj (M = 187.28)
Berechnet: C 64,13, H 11,30, N 7,48%;Calculated: C 64.13, H 11.30, N 7.48%;
gefunden: C 63,8, H 11,6, N 7,3%.found: C 63.8, H 11.6, N 7.3%.
Herstellung von 2-(4-Heptylpiperidyl-4-ox>y-äthanol a) 2-(N-Benzyl-4-heptylpiperidyI-4-oxy)-äthanolProduction of 2- (4-heptylpiperidyl-4-ox> y-ethanol a) 2- (N-Benzyl-4-heptylpiperidyI-4-oxy) ethanol
In einen Kolben werden 9,6 g Magnesiumspäne, 50 ml Äther, ein Jodkristall und 3 Tropfen Äthyljodid gegeben. Dann wird innerhalb von 1 h unter Stickstoff eine Lösung von 101,5 g n-Heptylbromid in 300 ml Äther zugegeben und 1 h weiter gerührt.9.6 g of magnesium shavings, 50 ml of ether, an iodine crystal and 3 drops of ethyl iodide are placed in a flask. Then a solution of 101.5 g of n-heptyl bromide in 300 ml of ether is added under nitrogen within 1 hour added and stirred for a further 1 h.
Zu der erhaltenen Lösung werden 46,6 g 8-Benzyl-1.4-dioxa-8-aza-spiro-[4,5]-decan in 1 I wasserfreiem Benzol zugegeben; nach dem Abdampfen des Äthers wird das Gemisch 16 h lang am Rückfluß gehalten. Nach dem Abkühlen der Lösung werden unter Rühren 20 ml Wasser und dann 400 ml einer gesättigten Ammoniumchloridlösung zugegeben.46.6 g of 8-benzyl-1,4-dioxa-8-aza-spiro [4.5] decane are added to the solution obtained added in 1 l of anhydrous benzene; after evaporation of the ether, the mixture is refluxed for 16 hours. To cooling the solution, 20 ml of water and then 400 ml of a saturated ammonium chloride solution are added with stirring admitted.
Nach dem Abdekantieren der organischen Phase und Abtrennung des Lösungsmittels unter vermindertem Druck wird der Rückstand rektifiziert. Man erhält so 40 g 2-{N-Benzy!-4-hepty]piperidyl-4-oxy)-äthanol, das ohne weitere Reinigung für die nachfolgende Stufe verwendet wird; Kp 150-20O=C.After the organic phase has been decanted off and the solvent has been separated off under reduced pressure The residue is rectified under pressure. This gives 40 g of 2- {N-Benzy! -4-hepty] piperidyl-4-oxy) ethanol, the is used for the next stage without further purification; 150-20O = C.
b) 2-(4-HeptyIpiperidyl-4-oxy) äthanolb) 2- (4-HeptyIpiperidyl-4-oxy) ethanol
40 g 2-(N-Benzy!-4-heptylpiperidyI-4-oxy)-äthanol werden in 300 ml absolutem Äthanol gelöst und bei40 g of 2- (N-Benzy! -4-heptylpiperidyI-4-oxy) ethanol are dissolved in 300 ml of absolute ethanol and in
13 1413 14
jO°C in Gegenwart von 0,4 g Paliadiumkohle (5%) farblosen Öls.10 ° C in the presence of 0.4 g of palladium carbon (5%) of colorless oil.
hydriert, bis die theoretische Menge Wasserstoff ab- Kp= 110—I3O°C/O,I33 mbar.hydrogenated until the theoretical amount of hydrogen decreases. Kp = 110-130 ° C./0.133 mbar.
sorbiTt ist, was etwa 5 h erfordert. Nach dem Abfil-sorbiTt is what takes about 5 hours. After filtering
trieren des Katalysators und Abdampfen des Äthanols Summenformel: C14HnNO2 (M =243,4)trating of the catalyst and evaporation of the ethanol Molecular formula: C 14 H n NO 2 (M = 243.4)
wird der Rückstand rektifiziert. Man erhall so 10,6 g -. Berechnet: N 5,53%:the residue is rectified. You get 10.6 g -. Calculated: N 5.53%:
2-(4-Heptylpiperidyl-4-oxy)-äthanol in Form eines gefunden: N 5,8%.2- (4-Heptylpiperidyl-4-oxy) -ethanol found in the form of: N 5.8%.
Claims (2)
1. Piperidinderivate der Formel I N-Benzylpiperidons der FormelPatent claims:
1. Piperidine derivatives of the formula I N-benzylpiperidones of the formula
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7117510A FR2137150B1 (en) | 1971-05-14 | 1971-05-14 | |
FR717117509A FR2137149B1 (en) | 1971-05-14 | 1971-05-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
DE2264903A1 DE2264903A1 (en) | 1975-08-28 |
DE2264903B2 DE2264903B2 (en) | 1981-02-19 |
DE2264903C3 true DE2264903C3 (en) | 1981-12-17 |
Family
ID=26216390
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2264903A Expired DE2264903C3 (en) | 1971-05-14 | 1972-05-10 | Piperidine derivatives and their preparation |
DE2222931A Expired DE2222931C3 (en) | 1971-05-14 | 1972-05-10 | Piperidinoalkylphenthiazines, processes for the production thereof and pharmaceutical compositions containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2222931A Expired DE2222931C3 (en) | 1971-05-14 | 1972-05-10 | Piperidinoalkylphenthiazines, processes for the production thereof and pharmaceutical compositions containing them |
Country Status (13)
Country | Link |
---|---|
JP (2) | JPS5118958B1 (en) |
AU (1) | AU461649B2 (en) |
BE (1) | BE783411A (en) |
CH (1) | CH553215A (en) |
DE (2) | DE2264903C3 (en) |
DK (1) | DK142318B (en) |
FI (1) | FI55657C (en) |
FR (2) | FR2137149B1 (en) |
GB (2) | GB1383773A (en) |
IL (1) | IL39296A (en) |
NL (1) | NL175824C (en) |
NO (1) | NO135365C (en) |
SE (2) | SE405973B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0621267A1 (en) * | 1993-04-07 | 1994-10-26 | Shell Internationale Researchmaatschappij B.V. | Spiropiperidine derivatives and their use as fungicides |
US20040072825A1 (en) * | 2000-12-19 | 2004-04-15 | Yves Lamberty | 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1344593A (en) * | 1961-11-25 | 1963-11-29 | Boehringer & Soehne Gmbh | Process for the preparation of novel alkoxy-piperidine derivatives and their salts |
-
1971
- 1971-05-14 FR FR717117509A patent/FR2137149B1/fr not_active Expired
- 1971-05-14 FR FR7117510A patent/FR2137150B1/fr not_active Expired
-
1972
- 1972-04-25 IL IL39296A patent/IL39296A/en unknown
- 1972-04-27 CH CH629072A patent/CH553215A/en not_active IP Right Cessation
- 1972-05-09 FI FI1305/72A patent/FI55657C/en active
- 1972-05-09 SE SE7206146A patent/SE405973B/en unknown
- 1972-05-10 DE DE2264903A patent/DE2264903C3/en not_active Expired
- 1972-05-10 DE DE2222931A patent/DE2222931C3/en not_active Expired
- 1972-05-12 NO NO1690/72A patent/NO135365C/en unknown
- 1972-05-12 AU AU42226/72A patent/AU461649B2/en not_active Expired
- 1972-05-12 BE BE783411A patent/BE783411A/en not_active IP Right Cessation
- 1972-05-13 JP JP47046917A patent/JPS5118958B1/ja active Pending
- 1972-05-15 DK DK240672AA patent/DK142318B/en not_active IP Right Cessation
- 1972-05-15 NL NLAANVRAGE7206504,A patent/NL175824C/en not_active IP Right Cessation
- 1972-05-15 GB GB2277272A patent/GB1383773A/en not_active Expired
- 1972-05-15 GB GB3172274A patent/GB1383774A/en not_active Expired
-
1975
- 1975-05-06 SE SE7505250A patent/SE418964B/en unknown
- 1975-11-25 JP JP50140299A patent/JPS5248988B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE783411A (en) | 1972-11-13 |
DE2264903A1 (en) | 1975-08-28 |
DE2222931B2 (en) | 1977-11-10 |
FI55657C (en) | 1979-09-10 |
FR2137150A1 (en) | 1972-12-29 |
SE418964B (en) | 1981-07-06 |
DK142318B (en) | 1980-10-13 |
IL39296A (en) | 1976-03-31 |
NO135365C (en) | 1977-03-30 |
GB1383773A (en) | 1974-02-12 |
AU461649B2 (en) | 1975-06-05 |
SE7505250L (en) | 1975-05-06 |
FR2137149A1 (en) | 1972-12-29 |
GB1383774A (en) | 1974-02-12 |
DE2222931A1 (en) | 1972-11-30 |
CH553215A (en) | 1974-08-30 |
FR2137150B1 (en) | 1975-01-17 |
NO135365B (en) | 1976-12-20 |
NL7206504A (en) | 1972-11-16 |
AU4222672A (en) | 1973-12-06 |
IL39296A0 (en) | 1972-06-28 |
FI55657B (en) | 1979-05-31 |
FR2137149B1 (en) | 1973-05-11 |
JPS5191267A (en) | 1976-08-10 |
NL175824C (en) | 1985-01-02 |
NL175824B (en) | 1984-08-01 |
DE2264903B2 (en) | 1981-02-19 |
SE405973B (en) | 1979-01-15 |
JPS5118958B1 (en) | 1976-06-14 |
DE2222931C3 (en) | 1978-07-06 |
JPS5248988B2 (en) | 1977-12-14 |
DK142318C (en) | 1981-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2760005C2 (en) | Optically active norpinene and process for their preparation | |
CH628012A5 (en) | METHOD FOR PRODUCING CYCLOPENTEN DERIVATIVES. | |
CH646147A5 (en) | 4,5-UNSATURATED PROSTANIC ACID DERIVATIVES. | |
DE2264903C3 (en) | Piperidine derivatives and their preparation | |
CH509297A (en) | Progestational and deciduogenic 17alpha-substituted-11 | |
DE2332707A1 (en) | TRICYCLIC TETRAHYDRONAPHTHALINE DERIVATIVES, THEIR SALTS, METHODS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
DE2057840C3 (en) | Process for the production of indole derivatives | |
CH628040A5 (en) | METHOD FOR PRODUCING NEW 4-HYDROXY-2H-NAPHTHO (2,1-E) -1,2-THIAZINE-3-CARBOXAMIDE-1,1-DIOXYDE. | |
DE2759994C2 (en) | Ketals of 4- (1-hydroxy-1-methylethyl) -3-cyclohexen-1-one and process for their preparation | |
Adams et al. | Structure of Monocrotaline. VII. 1 Structure of Retronecine and Related Bases | |
DD201792A5 (en) | PROCESS FOR PREPARING THE 2,3,4,5-TETRAHYDRO-1-BENZOXEPINE-3,5-DION DERIVATIVES | |
DE2150146C3 (en) | Process for the preparation of flavone 7-oxyacetic acid ethyl ester | |
DE2165109A1 (en) | Process for the preparation of alpha-methyl-beta- (3,4-dihydroxyphenyl) -alanine | |
DE2415765C2 (en) | ||
DE1670583A1 (en) | New piperidine derivatives | |
DE69011996T2 (en) | Process for the preparation of 1,4-dihydroxy-2-arylnaphthoate. | |
DE2435331C2 (en) | Analogs of prostanoic acids and processes for their preparation, as well as pharmaceuticals containing these analogs of prostanoic acids | |
EP0153689A2 (en) | Prostaglandin intermediates | |
DE1958646C3 (en) | 3,5-DimethyUsoxazoles Substituted in the 4-Position and their Preparation | |
AT215993B (en) | Process for the preparation of new 4-oxo-2- (haloalkyl) -2,3-dihydro- [benzo-1,3-oxazines] | |
DE2509780A1 (en) | TRIS- (2-HYDROXYARYL) -CYANURIC ACID ESTER | |
DE2100422A1 (en) | New esters and methods of making them | |
AT345843B (en) | PROCESS FOR THE PREPARATION OF NEW 4-HYDROXY-2H-NAPHTHO- (2,1-E) -1,2-THIAZINE-3-CARBOXAMIDE-1,1-DIOXIDE AND THE SALT THEREOF | |
AT233540B (en) | Process for the preparation of allene esters | |
AT349030B (en) | PROCESS FOR THE PRODUCTION OF NEW 8-HYDROXY-3-HALOGENMETHYL-4-ACETOXY-10-METHYLENE-2,9-DIOXATRICYCLO (4,3,1,03,7) DECANES OR OF THE APPROPRIATE 8-OXO DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OD | Request for examination | ||
8326 | Change of the secondary classification | ||
C3 | Grant after two publication steps (3rd publication) | ||
8339 | Ceased/non-payment of the annual fee |